Abstract The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous
efforts to develop therapeutic strategies that target severe acute respiratory syndrome …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
COVID-19, is a highly transmittable and pathogenic human coronavirus that first emerged in …

SARS-CoV-2 infection is still spreading worldwide, and new antiviral therapies are an urgent
need to complement the approved vaccine preparations. SARS-CoV-2 nps13 helicase is a …

SARS-CoV-2 is a coronavirus that emerged in 2019 and rapidly spread across the world
causing a deadly pandemic with tremendous social and economic costs. Healthcare …

Background SARS-CoV-2 is the causative agent of COVID-19. Overproduction and release
of proinflammatory cytokines are the underlying cause of severe COVID-19. Treatment of …

Ultrastructural studies of SARS-CoV-2 infected cells are crucial to better understand the
mechanisms of viral entry and budding within host cells. Here, we examined human airway …

The COVID-19 pandemic has emerged as the biggest life-threatening disease of this
century. Whilst vaccination should provide a long-term solution, this is pitted against the …

Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused substantial morbidity and …

The coronavirus 2019 (COVID-19) pandemic, caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), spread around the world with unprecedented …

Abstract SARS‐CoV‐2 (SCoV2) and its variants of concern pose serious challenges to the
public health. The variants increased challenges to vaccines, thus necessitating for …